Cod, I think that's a safe assumption.
The ann last year was 2nd March, but the FXS trial was announced 7 Dec as opposed to 12 Nov for Rett. So you'd guess somewhere between now and April we'd get an ann if successful.
April's getting more interesting every day.
Frankly I'm assuming not and that the FXS timeline follows the Rett one but delayed by a year.
On the other hand, BT notwithstanding, it took 6 months to meet with the FDA to plan the next trial and it's likely the silence on FXS is just the wheels moving very slowly in the background.
Rett Study, page-5
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.070(0.35%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $20.22 | $20.44 | $19.85 | $4.194M | 209.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2772 | $19.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 3310 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |